These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 35507051)
1. Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy. Deniffel D; Perlis N; Ghai S; Girgis S; Healy GM; Fleshner N; Hamilton R; Kulkarni G; Toi A; van der Kwast T; Zlotta A; Finelli A; Haider MA Eur Radiol; 2022 Nov; 32(11):7544-7554. PubMed ID: 35507051 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy. Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121 [TBL] [Abstract][Full Text] [Related]
3. Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study. Ahdoot M; Lebastchi AH; Long L; Wilbur AR; Gomella PT; Mehralivand S; Daneshvar MA; Yerram NK; O'Connor LP; Wang AZ; Gurram S; Bloom J; Siddiqui MM; Linehan WM; Merino M; Choyke PL; Pinsky P; Parnes H; Shih JH; Turkbey B; Wood BJ; Pinto PA; Eur Urol Oncol; 2022 Apr; 5(2):176-186. PubMed ID: 33846112 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the Prostate. Liu Y; Wang S; Xu G; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H J Magn Reson Imaging; 2023 Sep; 58(3):709-717. PubMed ID: 36773016 [TBL] [Abstract][Full Text] [Related]
5. Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer. Stabile A; Dell'Oglio P; Soligo M; De Cobelli F; Gandaglia G; Fossati N; Esposito A; Brembilla G; Karnes RJ; Montorsi F; Briganti A Eur Urol Oncol; 2021 Aug; 4(4):594-600. PubMed ID: 31204312 [TBL] [Abstract][Full Text] [Related]
6. A clinical available decision support scheme for optimizing prostate biopsy based on mpMRI. Hou Y; Jiang KW; Zhang J; Bao ML; Shi HB; Qu JR; Cheng G; Zhang YD Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):727-734. PubMed ID: 35067674 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5]. Liu Y; Yuan CW; Wu JY; Shen Q; Xiao JX; Zhao Z; Wang XY; Li XS; He ZS; Zhou LQ Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):812-817. PubMed ID: 37807733 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study. Avolio PP; Fasulo V; Sanchez-Salas R; Maffei D; Frego N; Lazzeri M; Paciotti M; Saita A; Hurle R; Guazzoni G; Casale P; Buffi NM; Lughezzani G World J Urol; 2023 Sep; 41(9):2335-2342. PubMed ID: 37418017 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy. Oderda M; Albisinni S; Benamran D; Calleris G; Ciccariello M; Dematteis A; Diamand R; Descotes JL; Fiard G; Forte V; Giacobbe A; Marquis A; Marra G; Messas A; Muto G; Peltier A; Rius L; Simone G; Roumeguere T; Faletti R; Gontero P Prostate; 2023 Feb; 83(2):162-168. PubMed ID: 36259316 [TBL] [Abstract][Full Text] [Related]
10. Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database. Barletta F; Mazzone E; Stabile A; Scuderi S; Brembilla G; de Angelis M; Cirulli GO; Cucchiara V; Gandaglia G; Karnes RJ; Roupret M; De Cobelli F; Montorsi F; Briganti A World J Urol; 2022 Nov; 40(11):2683-2688. PubMed ID: 36149448 [TBL] [Abstract][Full Text] [Related]
11. Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series. Stabile A; Barletta F; Motterle G; Pellegrino F; Sorce G; Mazzone E; Scuderi S; Cirulli GO; Cucchiara V; Esposito A; Gandaglia G; Fossati N; De Cobelli F; Montorsi F; Karnes RJ; Briganti A Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1137-1142. PubMed ID: 33941867 [TBL] [Abstract][Full Text] [Related]
12. Tailoring biopsy strategy in the MRI-fusion prostate biopsy era: systematic, targeted or neither? Jäderling F; Bergman M; Engel JC; Mortezavi A; Picker W; Haug ES; Eklund M; Nordström T BMC Urol; 2024 Aug; 24(1):168. PubMed ID: 39112967 [TBL] [Abstract][Full Text] [Related]
13. Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series. Pellegrino F; Stabile A; Mazzone E; Sorce G; Barletta F; De Angelis M; Brembilla G; Gandaglia G; De Cobelli F; Montorsi F; Briganti A Prostate; 2022 Sep; 82(12):1170-1175. PubMed ID: 35538401 [TBL] [Abstract][Full Text] [Related]
14. Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study. Porreca A; Del Giudice F; Giampaoli M; D'Agostino D; Romagnoli D; Corsi P; Del Rosso A; Maggi M; Chung BI; Ferro M; de Cobelli O; Lucarelli G; Schiavina R; De Berardinis E; Sciarra A; Busetto GM Medicine (Baltimore); 2020 Sep; 99(37):e22059. PubMed ID: 32925739 [TBL] [Abstract][Full Text] [Related]
15. Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy. Freifeld Y; Xi Y; Passoni N; Woldu S; Hornberger B; Goldberg K; Bagrodia A; Raj G; Margulis V; Cadeddu JA; Lotan Y; Francis F; Pedrosa I; G Roehrborn C; Costa DN Urol Oncol; 2019 Jan; 37(1):57-62. PubMed ID: 30446460 [TBL] [Abstract][Full Text] [Related]
16. Which protocol for prostate biopsies in patients with a positive MRI? Interest of systematic biopsies by sectors. Zambon A; Nguyen TA; Fourcade A; Segalen T; Saout K; Deruelle C; Joulin V; Tissot V; Doucet L; Fournier G; Valeri A Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):500-506. PubMed ID: 38114598 [TBL] [Abstract][Full Text] [Related]
17. Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary? Osses DF; Drost FH; Verbeek JFM; Luiting HB; van Leenders GJLH; Bangma CH; Krestin GP; Roobol MJ; Schoots IG BJU Int; 2020 Jul; 126(1):124-132. PubMed ID: 32232921 [TBL] [Abstract][Full Text] [Related]
18. Predictors of prostate cancer detection in MRI PI-RADS 3 lesions - Reality of a tertiary center. Araújo D; Gromicho A; Dias J; Bastos S; Maciel RM; Sabença A; Xambre L Arch Ital Urol Androl; 2023 Dec; 95(4):11830. PubMed ID: 38117217 [TBL] [Abstract][Full Text] [Related]
19. MRI-Targeted Prostate Fusion Biopsy: What Are We Missing outside the Target? Implications for Treatment Planning. Oderda M; Dematteis A; Calleris G; Diamand R; Gatti M; Marra G; Adans-Dester G; Al Salhi Y; Pastore A; Faletti R; Gontero P Curr Oncol; 2024 Jul; 31(7):4133-4140. PubMed ID: 39057180 [No Abstract] [Full Text] [Related]